Anergen, Inc., a Delaware Corporation
Records under this name other than patents Anergen, Inc., a Delaware Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Anergen, Inc., a Delaware Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,171,590 | Chemokine receptor peptide for inducing an immune response Lapsed on the fee record Ended Jan 9, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jan 9, 2013 | From the USPTO record |
| US 6,106,840 | MHC conjugates useful in ameliorating autoimmunity Lapsed on the fee record Ended Aug 22, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2012 | From the USPTO record |
| US 6,451,314 | MHC conjugates useful in ameliorating autoimmunity Term ended Ended no later than Jun 23, 2008 · From the USPTO record | Term ended | Ended no later than Jun 23, 2008 | From the USPTO record |
| US 6,218,132 | Method for monitoring T cell reactivity Lapsed on the fee record Ended Apr 17, 2005 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2005 | From the USPTO record |
| US 6,090,587 | Prokaryotic expression of MHC proteins Lapsed on the fee record Ended Jul 18, 2004 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2004 | From the USPTO record |
| US 6,060,309 | Immune mediators and related methods Lapsed on the fee record Ended May 9, 2004 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2004 | From the USPTO record |
| US 6,045,796 | Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease Lapsed on the fee record Ended Apr 4, 2004 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2004 | From the USPTO record |
| US 5,130,297 | Conjugates useful in ameliorating autoimmunity MHC-II-peptide Term ended Term ended no later than Jul 14, 2012 · Low confidence | Term ended | Term ended no later than Jul 14, 2012 | Low confidence |
| US 5,169,934 | Intracellularly cleavable compounds Term ended Term ended no later than Dec 8, 2012 · Low confidence | Term ended | Term ended no later than Dec 8, 2012 | Low confidence |
| US 5,194,425 | MHC-mediated toxic conjugates useful in ameliorating autoimmunity Term ended Term ended no later than Mar 16, 2013 · Low confidence | Term ended | Term ended no later than Mar 16, 2013 | Low confidence |